Table 1 Baseline demographic and clinical characteristics in patients with IPMN with/without AP
| Â | IPMN | P-value | |
|---|---|---|---|
AP (n = 11) | Non-AP (n = 36) | ||
Demography | Â | Â | Â |
Age | 62.0 (52.0–72.0) | 64.5 (57.5–69.5) | 0.555 |
Sex | Â | Â | 0.461 |
Male | 9 (81.8) | 23 (63.9) | Â |
Female | 2 (18.2) | 13 (36.1) | Â |
Smoking | 1 (9.1) | 17 (47.2) | 0.033 |
Alcohol consumption | 0 (0) | 4 (11.1) | 0.560 |
Hypertension | 1 (9.1) | 16 (44.4) | 0.039 |
Diabetes | 1 (9.1) | 8 (22.2) | 0.663 |
Family History | Â | Â | Â |
AP | 0 (0) | 0 (0) | Â |
Pancreatic tumors | 0 (0) | 0 (0) | Â |
AP occurrence times | Â | Â | Â |
1 | 8 (72.7) | Â | Â |
2 | 1 (9.1) | Â | Â |
3 | 2 (18.2) | Â | Â |
Laboratory results | Â | Â | Â |
Total bilirubin (µmol/L) | 11.8 (8.2–14.8) | 14.3 (10.3–42.2) | 0.158 |
CEA (ng/ml) | 1.5 (1.2–3.2) | 2.5 (1.5–4.4) | 0.299 |
CA199 (ng/ml) | 15.3 (7.3–29.5) | 12.9 (8.9–44.7) | 0.915 |